Lonza, the Swiss healthcare contract manufacturing and development organisation (CDMO), has appointed Wolfgang Wienand as chief executive officer, effective during the summer of 2024. Dr Wienand is currently CEO of the Swiss CDMO Siegfried Holding AG. He will succeed Albert M. Baehny, the ad interim CEO who will remain at Lonza for the transition before retiring. Prior to becoming CEO of Siegfried Holding in 2019, Dr Wienand was chief scientific officer and chief strategy officer. He holds a masters’ degree in chemistry from the University of Bonn and a PhD in organic and bioorganic chemistry from the University of Cologne, both in Germany.
Lonza announced the appointment on 2 April 2024.
Copyright 2024 Evernow Publishing Ltd.